US-based contract research organisation Quintiles Transnational has consolidated and expanded its Global Central Laboratories and Clinical Development Services units in Beijing to accommodate a growing business in China.
Last July the CRO invested $19 million in relocating and consolidating its Global Central Laboratories and Clinical Development Services operations in the US state of Georgia.
The more than 17,000 sq ft consolidated Quintiles China facility is located at Sun Dong Ann Plaza in Beijing, close to the company’s previous laboratory in the Peking Union Medical College Hospital. Laboratory space has expanded by 2,600 sq ft while CDS occupies 10,000 sq ft of the combined office area, a significant gain on its old, less than 3,000 sq ft facility.
The Global Central Laboratories operation has 13 employees and continues to add staff, Quintiles said. Staffing for CDS in Beijing also continues to grow and is expected to top 60 employees over the next 12 months.
According to Lai Lee Tan, head of clinical operations and general manager for Quintiles in China, the consolidation of the CDS and Global Central Laboratories operations into a single facility will improve coordination and efficiency for customers. “Our clinical development business is poised for rapid acceleration in China,” he commented. “The globalisation of clinical research is continuing to increase, and China is just beginning to see the rapid growth we have experienced in India, Australia and throughout Asia Pacific.”
